Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implant Market Research Report Information by Diagnosis & Treatment {(Diagnosis [Microbiological Culture Test, Polymerase Chain Reaction, and Imaging Studies {Computed Tomography (CT), Magnetic Resonance Imaging (MRI), and Ultrasonography}], Treatment(Antibiotics, Antimicrobial Therapy, and Surgery)}, by End User (Hospitals, Ambulatory Surgery Centers, and Others), by Region (North America, Europe, Asia-Pacific, and Rest of the World) Forecast till 2032
Market Overview
Diagnosis and Treatment of Staphylococcus Aureus Infection in Orthopedic Implants In 2022, the market was estimated to be worth USD 2.31 billion. The staphylococcus aureus infection diagnosis and treatment for orthopedic implant market industry is anticipated to experience a compound annual growth rate (CAGR) of 4.89% during the forecast period, increasing from USD 2.40 billion in 2023 to USD 3.87 billion by 2032. The market is experiencing growth due to the increasing prevalence of fractures and the increasing number of orthopedic surgeries associated with implants.
The demand for the diagnosis and treatment of staphylococcus aureus infections in orthopedic implants is on the rise due to the growing number of orthopedic surgeries. For example, Cleveland Clinic (US) reported in July 2023 that approximately 800,000 knee replacements are performed annually in the States. Additionally, the American Association of Hip and Knee Surgeons has identified prosthetic joint infection (PJI) as a severe issue that arises following total hip arthroplasty (THA), particularly when other health conditions are present, which increases the risk. The proportion of infections associated with staphylococcus aureus increased from 26.3% in 2008–2009 to 40% between 2020 and 2021.
Market segment insights
The Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implant Market segmentation is based on diagnosis and treatment. Diagnosis is further segmented into microbiological culture test, polymerase chain reaction, and imaging studies.
The Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implant Market segmentation is based on the end user, which includes hospitals, ambulatory surgical centers, and other entities.
Regional Perspectives
The market is segmented into the United States, Europe, China, Middle East & North Africa, and the Rest of the World by region. In 2022, the staphylococcus aureus infection diagnosis and treatment for orthopedic implant market in North America held the largest market share. This is a result of the increased prevalence of staphylococcus aureus infection in orthopedic implants, the superior healthcare infrastructure, and the increase in the number of orthopedic surgeries in the North American region.
The staphylococcus aureus infection diagnosis and treatment for orthopedic implants market in Europe is the second-largest market share, owing to the country's favorable reimbursement policies and the geriatric population. Additionally, the most significant market share was attributed to Germany in the staphylococcus aureus infection diagnosis and treatment for orthopedic implant market. The UK is anticipated to be the fastest-growing market in the European region.
It is anticipated that the Asia-Pacific staphylococcus aureus infection diagnosis and treatment for orthopedic implant market will experience substantial growth from 2023 to 2032. This is a result of the accelerated population growth, government initiatives and investments, and collaboration among healthcare stakeholders in the region.
The Middle East, Africa, and Latin America comprise the Rest of the World. The staphylococcus aureus infection diagnosis and treatment for orthopedic implant market in the regions is expected to experience growth as a result of ongoing research and development initiatives that are committed to the development of innovative diagnostic technologies, therapeutics, and preventive strategies.
Major Players
Xellia Pharmaceuticals (Germany), Wellona Pharma (India), Schwitz Biotech (India), Merck KGaA (Germany), Thermo Fisher Scientific Inc (US), BioMérieux SA (France), Siemens healthineers AG (Germany), Beckman Coulter Inc (US), Hoffmann-La Roche Ltd (Switzerland), and Pfizer Inc (US) are among the key companies in the Staphylococcus Aureus Infection Diagnosis and Treatment for Orthopedic Implant Market.
圖表清單 List of Tables & Figures
LIST OF TABLES
TABLE 1 QFD MODELING FOR MARKET SHARE ASSESSMENT
TABLE 2 INDICATIVE SHARE (%) FOR IMPLANTS AFFECTED BY STAPHYLOCOCCUS AUREUS BY REGION, (2022)
TABLE 3 TOTAL NUMBER OF JOINT REPLACEMENTS AND COMPLICATED FRACTURES REPAIRED WITH PLATES AND SCREWS BY GLOBAL, 2019-2023
TABLE 4 TOTAL NUMBER OF COMPLICATED FRACTURES AND JOINT REPLACEMENTS INFECTED, BY GLOBAL, 2019-2023
TABLE 5 TOTAL NUMBER OF COMPLICATED FRACTURES AND JOINT REPLACEMENTS INFECTED WITH STAPHYLOCOCCUS AUREUS (SA) INFECTION BY GLOBAL, 2019-2023
TABLE 6 TOTAL NUMBER OF COMPLICATED FRACTURES AND JOINT REPLACEMENTS REVISED SURGERIES ARE DONE BASED ON AN SA INFECTION BY GLOBAL, 2019-2023
TABLE 7 TOTAL NUMBER OF SYNOVIAL FLUID PUNCTURES AND TOTAL NUMBER OF SYNOVIAL FLUID PUNCTURES INFECTED WITH SA BY GLOBAL, 2019-2023
TABLE 8 GLOBAL STAPHYLOCOCCUS AUREUS INFECTION DIAGNOSIS AND TREATMENT FOR ORTHOPEDIC IMPLANT MARKET, BY DIAGNOSIS & TREATMENT, 2019–2032 (USD BILLION)
TABLE 9 GLOBAL STAPHYLOCOCCUS AUREUS INFECTION DIAGNOSIS AND TREATMENT FOR ORTHOPEDIC IMPLANT MARKET, FOR DIAGNOSIS, BY REGION, 2019–2032 (USD BILLION)
TABLE 10 GLOBAL STAPHYLOCOCCUS AUREUS INFECTION DIAGNOSIS AND TREATMENT FOR ORTHOPEDIC IMPLANT MARKET, FOR DIAGNOSIS, BY TYPE, 2019–2032 (USD BILLION)
TABLE 11 GLOBAL STAPHYLOCOCCUS AUREUS INFECTION DIAGNOSIS AND TREATMENT FOR ORTHOPEDIC IMPLANT MARKET, FOR MICROBIOLOGICAL CULTURE TEST, BY REGION, 2019–2032 (USD BILLION)
TABLE 12 GLOBAL STAPHYLOCOCCUS AUREUS INFECTION DIAGNOSIS AND TREATMENT FOR ORTHOPEDIC IMPLANT MARKET, FOR POLYMERASE CHAIN REACTION, BY REGION, 2019–2032 (USD BILLION)
TABLE 13 GLOBAL STAPHYLOCOCCUS AUREUS INFECTION DIAGNOSIS AND TREATMENT FOR ORTHOPEDIC IMPLANT MARKET, FOR IMAGING STUDIES, BY REGION, 2019–2032 (USD BILLION)
TABLE 14 GLOBAL STAPHYLOCOCCUS AUREUS INFECTION DIAGNOSIS AND TREATMENT FOR ORTHOPEDIC IMPLANT MARKET, FOR IMAGING STUDIES, BY TYPE, 2019–2032 (USD BILLION)
TABLE 15 GLOBAL STAPHYLOCOCCUS AUREUS INFECTION DIAGNOSIS AND TREATMENT FOR ORTHOPEDIC IMPLANT MARKET, FOR COMPUTED TOMOGRAPHY (CT), BY REGION, 2019–2032 (USD BILLION)
TABLE 16 GLOBAL STAPHYLOCOCCUS AUREUS INFECTION DIAGNOSIS AND TREATMENT FOR ORTHOPEDIC IMPLANT MARKET, FOR MAGNETIC RESONANCE IMAGING (MRI), BY REGION, 2019–2032 (USD BILLION)
TABLE 17 GLOBAL STAPHYLOCOCCUS AUREUS INFECTION DIAGNOSIS AND TREATMENT FOR ORTHOPEDIC IMPLANT MARKET, FOR ULTRASONOGRAPHY, BY REGION, 2019–2032 (USD BILLION)
TABLE 18 GLOBAL STAPHYLOCOCCUS AUREUS INFECTION DIAGNOSIS AND TREATMENT FOR ORTHOPEDIC IMPLANT MARKET, FOR TREATMENT, BY REGION, 2019–2032 (USD BILLION)
TABLE 19 GLOBAL STAPHYLOCOCCUS AUREUS INFECTION DIAGNOSIS AND TREATMENT FOR ORTHOPEDIC IMPLANT MARKET, FOR TREATMENT, BY TYPE, 2019–2032 (USD BILLION)
TABLE 20 GLOBAL STAPHYLOCOCCUS AUREUS INFECTION DIAGNOSIS AND TREATMENT FOR ORTHOPEDIC IMPLANT MARKET, FOR ANTIBIOTICS, BY REGION, 2019–2032 (USD BILLION)
TABLE 21 GLOBAL STAPHYLOCOCCUS AUREUS INFECTION DIAGNOSIS AND TREATMENT FOR ORTHOPEDIC IMPLANT MARKET, FOR ANTIMICROBIAL THERAPY, BY REGION, 2019–2032 (USD BILLION)
TABLE 22 GLOBAL STAPHYLOCOCCUS AUREUS INFECTION DIAGNOSIS AND TREATMENT FOR ORTHOPEDIC IMPLANT MARKET, FOR SURGERY, BY REGION, 2019–2032 (USD BILLION)
TABLE 23 GLOBAL STAPHYLOCOCCUS AUREUS INFECTION DIAGNOSIS AND TREATMENT FOR ORTHOPEDIC IMPLANT MARKET, BY END USER, 2019–2032 (USD BILLION)
TABLE 24 GLOBAL STAPHYLOCOCCUS AUREUS INFECTION DIAGNOSIS AND TREATMENT FOR ORTHOPEDIC IMPLANT MARKET, FOR HOSPITALS, BY REGION, 2019–2032 (USD BILLION)
TABLE 25 GLOBAL STAPHYLOCOCCUS AUREUS INFECTION DIAGNOSIS AND TREATMENT FOR ORTHOPEDIC IMPLANT MARKET, FOR AMBULATORY SURGERY CENTERS, BY REGION, 2019–2032 (USD BILLION)
TABLE 26 GLOBAL STAPHYLOCOCCUS AUREUS INFECTION DIAGNOSIS AND TREATMENT FOR ORTHOPEDIC IMPLANT MARKET, FOR OTHERS, BY REGION, 2019–2032 (USD BILLION)
TABLE 27 GLOBAL: STAPHYLOCOCCUS AUREUS INFECTION DIAGNOSIS AND TREATMENT FOR ORTHOPEDIC IMPLANT MARKET, BY REGION, 2019–2032 (USD BILLION)
TABLE 28 NORTH AMERICA: STAPHYLOCOCCUS AUREUS INFECTION DIAGNOSIS AND TREATMENT FOR ORTHOPEDIC IMPLANT MARKET, BY COUNTRY, 2019–2032 (USD BILLION)
TABLE 29 NORTH AMERICA: STAPHYLOCOCCUS AUREUS INFECTION DIAGNOSIS AND TREATMENT FOR ORTHOPEDIC IMPLANT MARKET, BY DIAGNOSIS & TREATMENT, 2019–2032 (USD BILLION)
TABLE 30 NORTH AMERICA: STAPHYLOCOCCUS AUREUS INFECTION DIAGNOSIS AND TREATMENT FOR ORTHOPEDIC IMPLANT MARKET, FOR DIAGNOSIS, BY TYPE, 2019-2032 (USD BILLION)
TABLE 31 NORTH AMERICA: STAPHYLOCOCCUS AUREUS INFECTION DIAGNOSIS AND TREATMENT FOR ORTHOPEDIC IMPLANT MARKET, FOR IMAGING STUDIES BY TYPE, 2019-2032 (USD BILLION)
TABLE 32 NORTH AMERICA: STAPHYLOCOCCUS AUREUS INFECTION DIAGNOSIS AND TREATMENT FOR ORTHOPEDIC IMPLANT MARKET, FOR TREATMENT, BY TYPE 2019–2032 (USD BILLION)
TABLE 33 NORTH AMERICA: STAPHYLOCOCCUS AUREUS INFECTION DIAGNOSIS AND TREATMENT FOR ORTHOPEDIC IMPLANT MARKET, BY END USER 2019–2032 (USD BILLION)
TABLE 34 US: STAPHYLOCOCCUS AUREUS INFECTION DIAGNOSIS AND TREATMENT FOR ORTHOPEDIC IMPLANT MARKET, BY DIAGNOSIS & TREATMENT, 2019–2032 (USD BILLION)
TABLE 35 US: STAPHYLOCOCCUS AUREUS INFECTION DIAGNOSIS AND TREATMENT FOR ORTHOPEDIC IMPLANT MARKET, FOR DIAGNOSIS, BY TYPE, 2019-2032 (USD BILLION)
TABLE 36 US: STAPHYLOCOCCUS AUREUS INFECTION DIAGNOSIS AND TREATMENT FOR ORTHOPEDIC IMPLANT MARKET, FOR IMAGING STUDIES BY TYPE, 2019-2032 (USD BILLION)
TABLE 37 US: STAPHYLOCOCCUS AUREUS INFECTION DIAGNOSIS AND TREATMENT FOR ORTHOPEDIC IMPLANT MARKET, FOR TREATMENT, BY TYPE 2019–2032 (USD BILLION)
TABLE 38 US: STAPHYLOCOCCUS AUREUS INFECTION DIAGNOSIS AND TREATMENT FOR ORTHOPEDIC IMPLANT MARKET, BY END USER 2019–2032 (USD BILLION)
TABLE 39 CANADA: STAPHYLOCOCCUS AUREUS INFECTION DIAGNOSIS AND TREATMENT FOR ORTHOPEDIC IMPLANT MARKET, BY DIAGNOSIS & TREATMENT, 2019–2032 (USD BILLION)
TABLE 40 CANADA: STAPHYLOCOCCUS AUREUS INFECTION DIAGNOSIS AND TREATMENT FOR ORTHOPEDIC IMPLANT MARKET, FOR DIAGNOSIS, BY TYPE, 2019-2032 (USD BILLION)
TABLE 41 CANADA: STAPHYLOCOCCUS AUREUS INFECTION DIAGNOSIS AND TREATMENT FOR ORTHOPEDIC IMPLANT MARKET, FOR IMAGING STUDIES BY TYPE, 2019-2032 (USD BILLION)
TABLE 42 CANADA: STAPHYLOCOCCUS AUREUS INFECTION DIAGNOSIS AND TREATMENT FOR ORTHOPEDIC IMPLANT MARKET, FOR TREATMENT, BY TYPE 2019–2032 (USD BILLION)
TABLE 43 CANADA: STAPHYLOCOCCUS AUREUS INFECTION DIAGNOSIS AND TREATMENT FOR ORTHOPEDIC IMPLANT MARKET, BY END USER 2019–2032 (USD BILLION)
TABLE 44 EUROPE: STAPHYLOCOCCUS AUREUS INFECTION DIAGNOSIS AND TREATMENT FOR ORTHOPEDIC IMPLANT MARKET, BY COUNTRY, 2019–2032 (USD BILLION)
TABLE 45 EUROPE: STAPHYLOCOCCUS AUREUS INFECTION DIAGNOSIS AND TREATMENT FOR ORTHOPEDIC IMPLANT MARKET, BY DIAGNOSIS & TREATMENT, 2019–2032 (USD BILLION)
TABLE 46 EUROPE: STAPHYLOCOCCUS AUREUS INFECTION DIAGNOSIS AND TREATMENT FOR ORTHOPEDIC IMPLANT MARKET, FOR DIAGNOSIS, BY TYPE, 2019-2032 (USD BILLION)
TABLE 47 EUROPE: STAPHYLOCOCCUS AUREUS INFECTION DIAGNOSIS AND TREATMENT FOR ORTHOPEDIC IMPLANT MARKET, FOR IMAGING STUDIES BY TYPE, 2019-2032 (USD BILLION)
TABLE 48 EUROPE: STAPHYLOCOCCUS AUREUS INFECTION DIAGNOSIS AND TREATMENT FOR ORTHOPEDIC IMPLANT MARKET, FOR TREATMENT, BY TYPE 2019–2032 (USD BILLION)
TABLE 49 EUROPE: STAPHYLOCOCCUS AUREUS INFECTION DIAGNOSIS AND TREATMENT FOR ORTHOPEDIC IMPLANT MARKET, BY END USER 2019–2032 (USD BILLION)
TABLE 50 GERMANY: STAPHYLOCOCCUS AUREUS INFECTION DIAGNOSIS AND TREATMENT FOR ORTHOPEDIC IMPLANT MARKET, BY DIAGNOSIS & TREATMENT, 2019–2032 (USD BILLION)
TABLE 51 GERMANY: STAPHYLOCOCCUS AUREUS INFECTION DIAGNOSIS AND TREATMENT FOR ORTHOPEDIC IMPLANT MARKET, FOR DIAGNOSIS, BY TYPE, 2019-2032 (USD BILLION)
TABLE 52 GERMANY: STAPHYLOCOCCUS AUREUS INFECTION DIAGNOSIS AND TREATMENT FOR ORTHOPEDIC IMPLANT MARKET, FOR IMAGING STUDIES BY TYPE, 2019-2032 (USD BILLION)
TABLE 53 GERMANY: STAPHYLOCOCCUS AUREUS INFECTION DIAGNOSIS AND TREATMENT FOR ORTHOPEDIC IMPLANT MARKET, FOR TREATMENT, BY TYPE 2019–2032 (USD BILLION)
TABLE 54 GERMANY: STAPHYLOCOCCUS AUREUS INFECTION DIAGNOSIS AND TREATMENT FOR ORTHOPEDIC IMPLANT MARKET, BY END USER 2019–2032 (USD BILLION)
TABLE 55 FRANCE: STAPHYLOCOCCUS AUREUS INFECTION DIAGNOSIS AND TREATMENT FOR ORTHOPEDIC IMPLANT MARKET, BY DIAGNOSIS & TREATMENT, 2019–2032 (USD BILLION)
TABLE 56 FRANCE: STAPHYLOCOCCUS AUREUS INFECTION DIAGNOSIS AND TREATMENT FOR ORTHOPEDIC IMPLANT MARKET, FOR DIAGNOSIS, BY TYPE, 2019-2032 (USD BILLION)
TABLE 57 FRANCE: STAPHYLOCOCCUS AUREUS INFECTION DIAGNOSIS AND TREATMENT FOR ORTHOPEDIC IMPLANT MARKET, FOR IMAGING STUDIES BY TYPE, 2019-2032 (USD BILLION)
TABLE 58 FRANCE: STAPHYLOCOCCUS AUREUS INFECTION DIAGNOSIS AND TREATMENT FOR ORTHOPEDIC IMPLANT MARKET, FOR TREATMENT, BY TYPE 2019–2032 (USD BILLION)
TABLE 59 FRANCE: STAPHYLOCOCCUS AUREUS INFECTION DIAGNOSIS AND TREATMENT FOR ORTHOPEDIC IMPLANT MARKET, BY END USER 2019–2032 (USD BILLION)
TABLE 60 UK: STAPHYLOCOCCUS AUREUS INFECTION DIAGNOSIS AND TREATMENT FOR ORTHOPEDIC IMPLANT MARKET, BY DIAGNOSIS & TREATMENT, 2019–2032 (USD BILLION)
TABLE 61 UK: STAPHYLOCOCCUS AUREUS INFECTION DIAGNOSIS AND TREATMENT FOR ORTHOPEDIC IMPLANT MARKET, FOR DIAGNOSIS, BY TYPE, 2019-2032 (USD BILLION)
TABLE 62 UK: STAPHYLOCOCCUS AUREUS INFECTION DIAGNOSIS AND TREATMENT FOR ORTHOPEDIC IMPLANT MARKET, FOR IMAGING STUDIES BY TYPE, 2019-2032 (USD BILLION)
TABLE 63 UK: STAPHYLOCOCCUS AUREUS INFECTION DIAGNOSIS AND TREATMENT FOR ORTHOPEDIC IMPLANT MARKET, FOR TREATMENT, BY TYPE 2019–2032 (USD BILLION)
TABLE 64 UK: STAPHYLOCOCCUS AUREUS INFECTION DIAGNOSIS AND TREATMENT FOR ORTHOPEDIC IMPLANT MARKET, BY END USER 2019–2032 (USD BILLION)
TABLE 65 ITALY: STAPHYLOCOCCUS AUREUS INFECTION DIAGNOSIS AND TREATMENT FOR ORTHOPEDIC IMPLANT MARKET, BY DIAGNOSIS & TREATMENT, 2019–2032 (USD BILLION)
TABLE 66 ITALY: STAPHYLOCOCCUS AUREUS INFECTION DIAGNOSIS AND TREATMENT FOR ORTHOPEDIC IMPLANT MARKET, FOR DIAGNOSIS, BY TYPE, 2019-2032 (USD BILLION)
TABLE 67 ITALY: STAPHYLOCOCCUS AUREUS INFECTION DIAGNOSIS AND TREATMENT FOR ORTHOPEDIC IMPLANT MARKET, FOR IMAGING STUDIES BY TYPE, 2019-2032 (USD BILLION)
TABLE 68 ITALY: STAPHYLOCOCCUS AUREUS INFECTION DIAGNOSIS AND TREATMENT FOR ORTHOPEDIC IMPLANT MARKET, FOR TREATMENT, BY TYPE 2019–2032 (USD BILLION)
TABLE 69 ITALY: STAPHYLOCOCCUS AUREUS INFECTION DIAGNOSIS AND TREATMENT FOR ORTHOPEDIC IMPLANT MARKET, BY END USER 2019–2032 (USD BILLION)
TABLE 70 SPAIN: STAPHYLOCOCCUS AUREUS INFECTION DIAGNOSIS AND TREATMENT FOR ORTHOPEDIC IMPLANT MARKET, BY DIAGNOSIS & TREATMENT, 2019–2032 (USD BILLION)
TABLE 71 SPAIN: STAPHYLOCOCCUS AUREUS INFECTION DIAGNOSIS AND TREATMENT FOR ORTHOPEDIC IMPLANT MARKET, FOR DIAGNOSIS, BY TYPE, 2019-2032 (USD BILLION)
TABLE 72 SPAIN: STAPHYLOCOCCUS AUREUS INFECTION DIAGNOSIS AND TREATMENT FOR ORTHOPEDIC IMPLANT MARKET, FOR IMAGING STUDIES BY TYPE, 2019-2032 (USD BILLION)
TABLE 73 SPAIN: STAPHYLOCOCCUS AUREUS INFECTION DIAGNOSIS AND TREATMENT FOR ORTHOPEDIC IMPLANT MARKET, FOR TREATMENT, BY TYPE 2019–2032 (USD BILLION)
TABLE 74 SPAIN: STAPHYLOCOCCUS AUREUS INFECTION DIAGNOSIS AND TREATMENT FOR ORTHOPEDIC IMPLANT MARKET, BY END USER 2019–2032 (USD BILLION)
TABLE 75 REST OF EUROPE: STAPHYLOCOCCUS AUREUS INFECTION DIAGNOSIS AND TREATMENT FOR ORTHOPEDIC IMPLANT MARKET, BY DIAGNOSIS & TREATMENT, 2019–2032 (USD BILLION)
TABLE 76 REST OF EUROPE: STAPHYLOCOCCUS AUREUS INFECTION DIAGNOSIS AND TREATMENT FOR ORTHOPEDIC IMPLANT MARKET, FOR DIAGNOSIS, BY TYPE, 2019-2032 (USD BILLION)
TABLE 77 REST OF EUROPE: STAPHYLOCOCCUS AUREUS INFECTION DIAGNOSIS AND TREATMENT FOR ORTHOPEDIC IMPLANT MARKET, FOR IMAGING STUDIES BY TYPE, 2019-2032 (USD BILLION)
TABLE 78 REST OF EUROPE: STAPHYLOCOCCUS AUREUS INFECTION DIAGNOSIS AND TREATMENT FOR ORTHOPEDIC IMPLANT MARKET, FOR TREATMENT, BY TYPE 2019–2032 (USD BILLION)
TABLE 79 REST OF EUROPE: STAPHYLOCOCCUS AUREUS INFECTION DIAGNOSIS AND TREATMENT FOR ORTHOPEDIC IMPLANT MARKET, BY END USER 2019–2032 (USD BILLION)
TABLE 80 ASIA-PACIFIC: STAPHYLOCOCCUS AUREUS INFECTION DIAGNOSIS AND TREATMENT FOR ORTHOPEDIC IMPLANT MARKET, BY COUNTRY, 2019–2032 (USD BILLION)
TABLE 81 ASIA-PACIFIC: STAPHYLOCOCCUS AUREUS INFECTION DIAGNOSIS AND TREATMENT FOR ORTHOPEDIC IMPLANT MARKET, BY DIAGNOSIS & TREATMENT, 2019–2032 (USD BILLION)
TABLE 82 ASIA-PACIFIC: STAPHYLOCOCCUS AUREUS INFECTION DIAGNOSIS AND TREATMENT FOR ORTHOPEDIC IMPLANT MARKET, FOR DIAGNOSIS, BY TYPE, 2019–2032 (USD BILLION)
TABLE 83 ASIA-PACIFIC: STAPHYLOCOCCUS AUREUS INFECTION DIAGNOSIS AND TREATMENT FOR ORTHOPEDIC IMPLANT MARKET, FOR IMAGING STUDIES, BY TYPE, 2019–2032 (USD BILLION)
TABLE 84 ASIA-PACIFIC: STAPHYLOCOCCUS AUREUS INFECTION DIAGNOSIS AND TREATMENT FOR ORTHOPEDIC IMPLANT MARKET, BY TREATMENT, 2019–2032 (USD BILLION)
TABLE 85 ASIA-PACIFIC: STAPHYLOCOCCUS AUREUS INFECTION DIAGNOSIS AND TREATMENT FOR ORTHOPEDIC IMPLANT MARKET, BY END USER, 2019–2032 (USD BILLION)
TABLE 86 CHINA: STAPHYLOCOCCUS AUREUS INFECTION DIAGNOSIS AND TREATMENT FOR ORTHOPEDIC IMPLANT MARKET, BY DIAGNOSIS & TREATMENT, 2019–2032 (USD BILLION)
TABLE 87 CHINA: STAPHYLOCOCCUS AUREUS INFECTION DIAGNOSIS AND TREATMENT FOR ORTHOPEDIC IMPLANT MARKET, FOR DIAGNOSIS, BY TYPE, 2019–2032 (USD BILLION)
TABLE 88 CHINA: STAPHYLOCOCCUS AUREUS INFECTION DIAGNOSIS AND TREATMENT FOR ORTHOPEDIC IMPLANT MARKET, FOR IMAGING STUDIES, BY TYPE, 2019–2032 (USD BILLION)
TABLE 89 CHINA: STAPHYLOCOCCUS AUREUS INFECTION DIAGNOSIS AND TREATMENT FOR ORTHOPEDIC IMPLANT MARKET, BY TREATMENT, 2019–2032 (USD BILLION)
TABLE 90 CHINA: STAPHYLOCOCCUS AUREUS INFECTION DIAGNOSIS AND TREATMENT FOR ORTHOPEDIC IMPLANT MARKET, BY END USER, 2019–2032 (USD BILLION)
TABLE 91 INDIA: STAPHYLOCOCCUS AUREUS INFECTION DIAGNOSIS AND TREATMENT FOR ORTHOPEDIC IMPLANT MARKET, BY DIAGNOSIS & TREATMENT, 2019–2032 (USD BILLION)
TABLE 92 INDIA: STAPHYLOCOCCUS AUREUS INFECTION DIAGNOSIS AND TREATMENT FOR ORTHOPEDIC IMPLANT MARKET, FOR DIAGNOSIS, BY TYPE, 2019–2032 (USD BILLION)
TABLE 93 INDIA: STAPHYLOCOCCUS AUREUS INFECTION DIAGNOSIS AND TREATMENT FOR ORTHOPEDIC IMPLANT MARKET, FOR IMAGING STUDIES, BY TYPE, 2019–2032 (USD BILLION)
TABLE 94 INDIA: STAPHYLOCOCCUS AUREUS INFECTION DIAGNOSIS AND TREATMENT FOR ORTHOPEDIC IMPLANT MARKET, BY TREATMENT, 2019–2032 (USD BILLION)
TABLE 95 INDIA: STAPHYLOCOCCUS AUREUS INFECTION DIAGNOSIS AND TREATMENT FOR ORTHOPEDIC IMPLANT MARKET, BY END USER, 2019–2032 (USD BILLION)
TABLE 96 JAPAN: STAPHYLOCOCCUS AUREUS INFECTION DIAGNOSIS AND TREATMENT FOR ORTHOPEDIC IMPLANT MARKET, BY DIAGNOSIS & TREATMENT, 2019–2032 (USD BILLION)
TABLE 97 JAPAN: STAPHYLOCOCCUS AUREUS INFECTION DIAGNOSIS AND TREATMENT FOR ORTHOPEDIC IMPLANT MARKET, FOR DIAGNOSIS, BY TYPE, 2019–2032 (USD BILLION)
TABLE 98 JAPAN: STAPHYLOCOCCUS AUREUS INFECTION DIAGNOSIS AND TREATMENT FOR ORTHOPEDIC IMPLANT MARKET, FOR IMAGING STUDIES, BY TYPE, 2019–2032 (USD BILLION)
TABLE 99 JAPAN: STAPHYLOCOCCUS AUREUS INFECTION DIAGNOSIS AND TREATMENT FOR ORTHOPEDIC IMPLANT MARKET, BY TREATMENT, 2019–2032 (USD BILLION)
TABLE 100 JAPAN: STAPHYLOCOCCUS AUREUS INFECTION DIAGNOSIS AND TREATMENT FOR ORTHOPEDIC IMPLANT MARKET, BY END USER, 2019–2032 (USD BILLION)
TABLE 101 SOUTH KOREA: STAPHYLOCOCCUS AUREUS INFECTION DIAGNOSIS AND TREATMENT FOR ORTHOPEDIC IMPLANT MARKET, BY DIAGNOSIS & TREATMENT, 2019–2032 (USD BILLION)
TABLE 102 SOUTH KOREA: STAPHYLOCOCCUS AUREUS INFECTION DIAGNOSIS AND TREATMENT FOR ORTHOPEDIC IMPLANT MARKET, FOR DIAGNOSIS, BY TYPE, 2019–2032 (USD BILLION)
TABLE 103 SOUTH KOREA: STAPHYLOCOCCUS AUREUS INFECTION DIAGNOSIS AND TREATMENT FOR ORTHOPEDIC IMPLANT MARKET, FOR IMAGING STUDIES, BY TYPE, 2019–2032 (USD BILLION)
TABLE 104 SOUTH KOREA: STAPHYLOCOCCUS AUREUS INFECTION DIAGNOSIS AND TREATMENT FOR ORTHOPEDIC IMPLANT MARKET, BY TREATMENT, 2019–2032 (USD BILLION)
TABLE 105 SOUTH KOREA: STAPHYLOCOCCUS AUREUS INFECTION DIAGNOSIS AND TREATMENT FOR ORTHOPEDIC IMPLANT MARKET, BY END USER, 2019–2032 (USD BILLION)
TABLE 106 AUSTRALIA: STAPHYLOCOCCUS AUREUS INFECTION DIAGNOSIS AND TREATMENT FOR ORTHOPEDIC IMPLANT MARKET, BY DIAGNOSIS & TREATMENT, 2019–2032 (USD BILLION)
TABLE 107 AUSTRALIA: STAPHYLOCOCCUS AUREUS INFECTION DIAGNOSIS AND TREATMENT FOR ORTHOPEDIC IMPLANT MARKET, FOR DIAGNOSIS, BY TYPE, 2019–2032 (USD BILLION)
TABLE 108 AUSTRALIA: STAPHYLOCOCCUS AUREUS INFECTION DIAGNOSIS AND TREATMENT FOR ORTHOPEDIC IMPLANT MARKET, FOR IMAGING STUDIES, BY TYPE, 2019–2032 (USD BILLION)
TABLE 109 AUSTRALIA: STAPHYLOCOCCUS AUREUS INFECTION DIAGNOSIS AND TREATMENT FOR ORTHOPEDIC IMPLANT MARKET, BY TREATMENT, 2019–2032 (USD BILLION)
TABLE 110 AUSTRALIA: STAPHYLOCOCCUS AUREUS INFECTION DIAGNOSIS AND TREATMENT FOR ORTHOPEDIC IMPLANT MARKET, BY END USER, 2019–2032 (USD BILLION)
TABLE 111 REST OF ASIA-PACIFIC: STAPHYLOCOCCUS AUREUS INFECTION DIAGNOSIS AND TREATMENT FOR ORTHOPEDIC IMPLANT MARKET, BY DIAGNOSIS & TREATMENT, 2019–2032 (USD BILLION)
TABLE 112 REST OF ASIA-PACIFIC: STAPHYLOCOCCUS AUREUS INFECTION DIAGNOSIS AND TREATMENT FOR ORTHOPEDIC IMPLANT MARKET, FOR DIAGNOSIS, BY TYPE, 2019–2032 (USD BILLION)
TABLE 113 REST OF ASIA-PACIFIC: STAPHYLOCOCCUS AUREUS INFECTION DIAGNOSIS AND TREATMENT FOR ORTHOPEDIC IMPLANT MARKET, FOR IMAGING STUDIES, BY TYPE, 2019–2032 (USD BILLION)
TABLE 114 REST OF ASIA-PACIFIC: STAPHYLOCOCCUS AUREUS INFECTION DIAGNOSIS AND TREATMENT FOR ORTHOPEDIC IMPLANT MARKET, BY TREATMENT, 2019–2032 (USD BILLION)
TABLE 115 REST OF ASIA-PACIFIC: STAPHYLOCOCCUS AUREUS INFECTION DIAGNOSIS AND TREATMENT FOR ORTHOPEDIC IMPLANT MARKET, BY END USER, 2019–2032 (USD BILLION)
TABLE 116 REST OT THE WORLD: STAPHYLOCOCCUS AUREUS INFECTION DIAGNOSIS AND TREATMENT FOR ORTHOPEDIC IMPLANT MARKET, BY REGION, 2019–2032 (USD BILLION)
TABLE 117 REST OF THE WORLD: STAPHYLOCOCCUS AUREUS INFECTION DIAGNOSIS AND TREATMENT FOR ORTHOPEDIC IMPLANT MARKET, BY DIAGNOSIS & TREATMENT, 2019–2032 (USD BILLION)
TABLE 118 REST OF THE WORLD: STAPHYLOCOCCUS AUREUS INFECTION DIAGNOSIS AND TREATMENT FOR ORTHOPEDIC IMPLANT MARKET, FOR DIAGNOSIS, BY TYPE, 2019–2032 (USD BILLION)
TABLE 119 REST OF THE WORLD: STAPHYLOCOCCUS AUREUS INFECTION DIAGNOSIS AND TREATMENT FOR ORTHOPEDIC IMPLANT MARKET, FOR IMAGING STUDIES, BY TYPE, 2019–2032 (USD BILLION)
TABLE 120 REST OF THE WORLD: STAPHYLOCOCCUS AUREUS INFECTION DIAGNOSIS AND TREATMENT FOR ORTHOPEDIC IMPLANT MARKET, BY TREATMENT, 2019–2032 (USD BILLION)
TABLE 121 REST OF THE WORLD: STAPHYLOCOCCUS AUREUS INFECTION DIAGNOSIS AND TREATMENT FOR ORTHOPEDIC IMPLANT MARKET, BY END USER, 2019–2032 (USD BILLION)
TABLE 122 MIDDLE EAST & AFRICA: STAPHYLOCOCCUS AUREUS INFECTION DIAGNOSIS AND TREATMENT FOR ORTHOPEDIC IMPLANT MARKET, BY DIAGNOSIS & TREATMENT, 2019–2032 (USD BILLION)
TABLE 123 MIDDLE EAST & AFRICA: STAPHYLOCOCCUS AUREUS INFECTION DIAGNOSIS AND TREATMENT FOR ORTHOPEDIC IMPLANT MARKET, FOR DIAGNOSIS, BY TYPE, 2019–2032 (USD BILLION)
TABLE 124 MIDDLE EAST & AFRICA: STAPHYLOCOCCUS AUREUS INFECTION DIAGNOSIS AND TREATMENT FOR ORTHOPEDIC IMPLANT MARKET, FOR IMAGING STUDIES, BY TYPE, 2019–2032 (USD BILLION)
TABLE 125 MIDDLE EAST & AFRICA: STAPHYLOCOCCUS AUREUS INFECTION DIAGNOSIS AND TREATMENT FOR ORTHOPEDIC IMPLANT MARKET, BY TREATMENT, 2019–2032 (USD BILLION)
TABLE 126 MIDDLE EAST & AFRICA: STAPHYLOCOCCUS AUREUS INFECTION DIAGNOSIS AND TREATMENT FOR ORTHOPEDIC IMPLANT MARKET, BY END USER, 2019–2032 (USD BILLION)
TABLE 127 LATIN AMERICA: STAPHYLOCOCCUS AUREUS INFECTION DIAGNOSIS AND TREATMENT FOR ORTHOPEDIC IMPLANT MARKET, BY DIAGNOSIS & TREATMENT, 2019–2032 (USD BILLION)
TABLE 128 LATIN AMERICA: STAPHYLOCOCCUS AUREUS INFECTION DIAGNOSIS AND TREATMENT FOR ORTHOPEDIC IMPLANT MARKET, FOR DIAGNOSIS, BY TYPE, 2019–2032 (USD BILLION)
TABLE 129 LATIN AMERICA: STAPHYLOCOCCUS AUREUS INFECTION DIAGNOSIS AND TREATMENT FOR ORTHOPEDIC IMPLANT MARKET, FOR IMAGING STUDIES, BY TYPE, 2019–2032 (USD BILLION)
TABLE 130 LATIN AMERICA: STAPHYLOCOCCUS AUREUS INFECTION DIAGNOSIS AND TREATMENT FOR ORTHOPEDIC IMPLANT MARKET, BY TREATMENT, 2019–2032 (USD BILLION)
TABLE 131 LATIN AMERICA: STAPHYLOCOCCUS AUREUS INFECTION DIAGNOSIS AND TREATMENT FOR ORTHOPEDIC IMPLANT MARKET, BY END USER, 2019–2032 (USD BILLION)
TABLE 132 PUBLIC PLAYERS STOCK SUMMARY
TABLE 133 COMPARATIVE ANALYSIS: KEY PLAYERS FINANICAL
TABLE 134 PRODUCT APPROVAL
TABLE 135 XELLIA PHARMACEUTICALS: PRODUCTS OFFERED
TABLE 136 WELLONA PHARMA.: PRODCUTS OFFERED
TABLE 137 SCHWITZ BIOTECH: PRODUCTS OFFERED
TABLE 138 MERCK KGAA: PRODUCTS OFFERED
TABLE 139 THERMO FISHER SCIENTIFIC INC: PRODUCTS OFFERED
TABLE 140 BIOMÉRIEUX SA: PRODUCTS OFFERED
TABLE 141 SIEMENS HEALTHINEERS AG: PRODUCTS OFFERED
TABLE 142 SIEMENS HEALTHINEERS AG: KEY DEVELOPMENTS
TABLE 143 BECKMAN COULTER INC: PRODUCTS OFFERED
TABLE 144 F. HOFFMANN-LA ROCHE LTD: PRODUCTS OFFERED
TABLE 145 PFIZER INC: PRODUCT OFFERED
LIST OF FIGURES
FIGURE 1 GLOBAL STAPHYLOCOCCUS AUREUS INFECTION DIAGNOSIS AND TREATMENT FOR ORTHOPEDIC IMPLANT MARKET: STRUCTURE
FIGURE 2 GLOBAL STAPHYLOCOCCUS AUREUS INFECTION DIAGNOSIS AND TREATMENT FOR ORTHOPEDIC IMPLANT MARKET: MARKET GROWTH FACTOR ANALYSIS (2022-2032)
FIGURE 3 DRIVER IMPACT ANALYSIS (2023-2032)
FIGURE 4 RESTRAINT IMPACT ANALYSIS (2022-2032)
FIGURE 5 PORTER'S FIVE FORCES ANALYSIS: GLOBAL STAPHYLOCOCCUS AUREUS INFECTION DIAGNOSIS AND TREATMENT FOR ORTHOPEDIC IMPLANT MARKET
FIGURE 6 GLOBAL STAPHYLOCOCCUS AUREUS INFECTION DIAGNOSIS AND TREATMENT FOR ORTHOPEDIC IMPLANT MARKET, DIAGNOSIS & TREATMENT SEGMENT ATTRACTIVENESS, 2022-2032 (USD BILLION)
FIGURE 7 GLOBAL STAPHYLOCOCCUS AUREUS INFECTION DIAGNOSIS AND TREATMENT FOR ORTHOPEDIC IMPLANT MARKET, BY DIAGNOSIS & TREATMENT, 2022 & 2032 (USD BILLION)
FIGURE 8 GLOBAL STAPHYLOCOCCUS AUREUS INFECTION DIAGNOSIS AND TREATMENT FOR ORTHOPEDIC IMPLANT MARKET SHARE (%), BY DIAGNOSIS & TREATMENT, 2022
FIGURE 9 GLOBAL STAPHYLOCOCCUS AUREUS INFECTION DIAGNOSIS AND TREATMENT FOR ORTHOPEDIC IMPLANT MARKET, END USER SEGMENT ATTRACTIVENESS, 2022-2032 (USD BILLION)
FIGURE 10 GLOBAL STAPHYLOCOCCUS AUREUS INFECTION DIAGNOSIS AND TREATMENT FOR ORTHOPEDIC IMPLANT MARKET, BY END USER, 2022 & 2032 (USD BILLION)
FIGURE 11 GLOBAL STAPHYLOCOCCUS AUREUS INFECTION DIAGNOSIS AND TREATMENT FOR ORTHOPEDIC IMPLANT MARKET SHARE (%), BY END USER, 2022
FIGURE 12 GLOBAL: STAPHYLOCOCCUS AUREUS INFECTION DIAGNOSIS AND TREATMENT FOR ORTHOPEDIC IMPLANT MARKET, BY REGION, 2022 & 2032 (USD BILLION)
FIGURE 13 GLOBAL: STAPHYLOCOCCUS AUREUS INFECTION DIAGNOSIS AND TREATMENT FOR ORTHOPEDIC IMPLANT MARKET SHARE (%), BY REGION, 2022
FIGURE 14 NORTH AMERICA STAPHYLOCOCCUS AUREUS INFECTION DIAGNOSIS AND TREATMENT FOR ORTHOPEDIC IMPLANT MARKET, 2019-2032 (USD BILLION)
FIGURE 15 NORTH AMERICA: STAPHYLOCOCCUS AUREUS INFECTION DIAGNOSIS AND TREATMENT FOR ORTHOPEDIC IMPLANT MARKET, BY COUNTRY, 2022 & 2032 (USD BILLION)
FIGURE 16 NORTH AMERICA: STAPHYLOCOCCUS AUREUS INFECTION DIAGNOSIS AND TREATMENT FOR ORTHOPEDIC IMPLANT MARKET SHARE (%), BY COUNTRY, 2022
FIGURE 17 EUROPE STAPHYLOCOCCUS AUREUS INFECTION DIAGNOSIS AND TREATMENT FOR ORTHOPEDIC IMPLANT MARKET, 2019-2032 (USD BILLION)
FIGURE 18 EUROPE: STAPHYLOCOCCUS AUREUS INFECTION DIAGNOSIS AND TREATMENT FOR ORTHOPEDIC IMPLANT MARKET, BY COUNTRY, 2022 & 2032 (USD BILLION)
FIGURE 19 EUROPE: STAPHYLOCOCCUS AUREUS INFECTION DIAGNOSIS AND TREATMENT FOR ORTHOPEDIC IMPLANT MARKET SHARE (%), BY COUNTRY, 2022
FIGURE 20 ASIA-PACIFIC MARKET ANALYSIS: TWO-PIECE EMPTY HARD CAPSULE MARKET, 2019-2030 (USD BILLION)
FIGURE 21 ASIA-PACIFIC: STAPHYLOCOCCUS AUREUS INFECTION DIAGNOSIS AND TREATMENT FOR ORTHOPEDIC IMPLANT MARKET, BY COUNTRY, 2022 & 2032 (USD BILLION)
FIGURE 22 ASIA-PACIFIC: STAPHYLOCOCCUS AUREUS INFECTION DIAGNOSIS AND TREATMENT FOR ORTHOPEDIC IMPLANT MARKET SHARE (%), BY COUNTRY, 2022
FIGURE 23 REST OF THE WORLD MARKET ANALYSIS: STAPHYLOCOCCUS AUREUS INFECTIONS FOR ORTHOPEDIC IMPLANT MARKET, 2019-2032 (USD BILLION)
FIGURE 24 REST OT THE WORLD: STAPHYLOCOCCUS AUREUS INFECTION DIAGNOSIS AND TREATMENT FOR ORTHOPEDIC IMPLANT MARKET, BY REGION, 2022 & 2032 (USD BILLION)
FIGURE 25 REST OT THE WORLD: STAPHYLOCOCCUS AUREUS INFECTION DIAGNOSIS AND TREATMENT FOR ORTHOPEDIC IMPLANT MARKET SHARE (%), BY REGION, 2022
FIGURE 26 STAPHYLOCOCCUS AUREUS INFECTION DIAGNOSIS AND TREATMENT FOR ORTHOPEDIC IMPLANT MARKET PLAYERS: COMPETITIVE ANALSIS, 2022
FIGURE 27 COMPETITOR DASHBOARD: GLOBAL STAPHYLOCOCCUS AUREUS INFECTION DIAGNOSIS AND TREATMENT FOR ORTHOPEDIC IMPLANT MARKET
FIGURE 28 MERCK KGAA: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 29 MERCK KGAA: SWOT ANALYSIS
FIGURE 30 THERMO FISHER SCIENTIFIC INC: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 31 THERMO FISHER SCIENTIFIC INC: SWOT ANALYSIS
FIGURE 32 BIOMÉRIEUX SA: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 33 BIOMÉRIEUX SA: SWOT ANALYSIS
FIGURE 34 SIEMENS HEALTHINEERS AG: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 35 SIEMENS HEALTHINEERS AG: SWOT ANALYSIS
FIGURE 36 F. HOFFMANN-LA ROCHE LTD: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 37 F. HOFFMANN-LA ROCHE LTD: SWOT ANALYSIS
FIGURE 38 PFIZER INC: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 39 PFIZER INC: SWOT ANALYSIS
量子訊息有限公司為 Market Research Future 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們